Investment Q&A

Q: ccl.b is getting whipped today. Only news I see on it is expansion plans for Mexico plant. Can you add insight on ccl.b performance today?

thanks

Q: Market is droping like crazy should we still hold?.

Q: In an answer today you said that BEP.UN is not eligible for the dividend tax credit but indicated that POT is. I hold bep in a non-registered account. If it is not eligible I would consider it better for my RRSP. Is there a rule of thumb or a resource anywhere that can be used to figure this out.

Q: what are your views on sask potash

Q: I'm now in the process of identifying my positions as income, balanced or growth and then tracking these three groups, in addition to the whole portfolio. For Boyd, I think it would be earmarked 'balanced' and so would Stantec, rather than 'income' without getting into the reasons for this. How do you see it?......thanks, again.........tom

Q: Peter, with the government in Alberta and the potential government in Ottawa that is unfriendly to business I am looking for companies that pay a dividend that qualifies for Canadian dividend tax credit, pays in American dollars and has most of its business in the U.S. I believe Brookfield, Pure Muti family reit would qualify. Could you please give me a few more that pay 5 percent dividend or more, Thank you Ken

Q: Hi 5i Team.
I currently have a family RESP started 5yrs ago for my 2 1/2 and 5 year old. I am maximizing annual contributions and expect the government top up also, so will add $6,000 per year. The funds will not be needed for 12- 15 years and I am willing to weather some volatility. Currently I have the following stocks in the portfolio BNS,BCE,CU,DHX.B,EMA,ENB,XTC,FTS,GEI,L,PPL,BIN,RY,TCK.B,T,TD. They are anywhere from 3-10% weighting. What stocks would you suggest adding to this portfolio?
Thanks

Q: What is your current opinion on DexCom? Growth continues to be compelling. Do you still consider it high risk? Thank you.

Q: Hi guys, Any opinion on this name ? Also, if you could please recommend a U.S. consumer etf. Thanks

Q: What do you think about this company in the US as a long term investment? Is it priced high relatively? I noticed it in the fintech rankings. Thanks. Regards, Shyam

Q: Hi,

I've owned ZUH for the past two years and it has done well. As you know it is hedged to the U.S. Dollar. Two questions,
1) what do you see happening in the next few years re our dollar vs theirs?
2) do you think I'm better off with another healthcare company?

Q: Hey folks, I have a position in CWL. Earlier this week their was a drop on (for CWL) big volume. Is that the company that had accumulated a position to try to buy the firm selling? Will there be more of this pressure near term? What do you think of this stock at this price? Thanks for your insight.

Q: This question is about the fixed income allocation in my portfolio. Most of it is invested in a 10 year ladder of provincial and corporate bonds. Given today's low interest rate environment and the slim prospects of rising rates in the foreseeable future, do you think it is wise to stick with this strategy?

Q: XAU has dropped precipitously lately. Have there been any particular events / catalysts that might explain this?

Thanks!

Q: I was wondering about IT now that they have a poison pill in place to protect them from a takeover. would they do this because their shares are cheap or has some other company been sniffing around. thanks.

Q: In a recent report by Veritas they feel LNR has significantly more upside than MG.

I currently own MG do you think it is worth selling and substitute LNR. Here are Veritas's comments:

Linamar (LNR) - $69.41 – Veritas: Buy (PT $97); RBC CM: Sector Perform (PT $91)
Magna International (MG) - $62.34 – Veritas: Buy (PT $62.70); RBC CM: Outperform (PT $68)
The company now warns that the current emission issue could impact roughly 11 million vehicles (some models from 2009- 2015). In prior recall related events (i.e. GM, Hyundai, and Toyota), the ultimate loss of market share was largely short-term in nature. As a result, Vertias suspects that the fallout of VW’s emissions-gate could be short lived, with VW losing less than 25% of its U.S. sales. Between Linamar and Magna, the auto-parts supplier we cover, Linamar has less exposure to VW. In 2014, VW was not among LNR’s top four customers (suggesting VW contributes less than 7% of LNR revenue); in case of Magna, VW contributed roughly 11% of MGA’s 2014 revenues. Between Linamar and Magna, Linamar has less exposure to VW. Thus, for anyone who is looking to invest in a mid-cap autoparts supplier, Veritas recommends buying LNR. That said, given the diversified customer base Magna has, Veritas believe that the impact of VW event will be minimal, as VW lost business will be picked by other OEMs.

Q: I am thinking of switching some funds within my portfolio healthcare allocation by selling PFE to purchase GUD based on the many positive statements that you have made about Knight and the recent 5i report on the company. I find GUD an interesting company but difficult to value relative to PFE. Income is not required from the holding, and invested funds are not required for 5 years plus. Do you believe that there is enough upside to GUD to offset realized capital gain taxes on a PFE sale, loss of the PFE dividend stream, possible additional future currency gains on PFE, and additional capital gains potential on PFE as they improve their operations further? In other words, are you confident enough in Knights upside potential that you would make the switch in your portfolio if you currently held PFE?

Thanks!

Q: I asked a question last week and have not recieved an answer. Was the question too involved?

Q: I have a half position in Agrium my sole agriculture stock should I add to it with the recent drop or go with afn. I am retired, conservative income stocks primarily. Thanks for your incite.

Q: Can you comment on the real return of this fund ? I note that Google Finance indicates a yield of 3.9%, but the iShares website shows a Total Return for 1 year of 2.76%. Also, some commentators think you have to look at total return to maturity, since the price of some of the bonds in the fund may be higher than face value, so when the bonds mature, you have a built-in capital loss which reduces your net returns. What accounts for the decline in price of this ETF over the past year (from 19.75 to 19.25) and do you think declines are likely to continue ?